RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
-14.76%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.19B
AUM Growth
-$125M
(-9.5%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
132
New
11
Increased
77
Reduced
4
Closed
5
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$10.9M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$10.4M |
| 3 |
Edwards Lifesciences
EW
|
$6.7M |
| 4 |
Alkermes
ALKS
|
$6.65M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$6.63M |
Top Sells
| 1 |
Idexx Laboratories
IDXX
|
$9.3M |
| 2 |
RLYP
RELYPSA INC COM
RLYP
|
$7.14M |
| 3 |
AbbVie
ABBV
|
$5.18M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$4.67M |
| 5 |
Travere Therapeutics
TVTX
|
$2.1M |
Sector Composition
| 1 | Healthcare | 77.92% |
| 2 | Financials | 3.87% |
| 3 | Industrials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
AbbVie
ABBV
$375B
| – | – |
-87,500
| Closed | -$5.18M |
|
|
127
Idexx Laboratories
IDXX
$51.4B
| – | – |
-127,500
| Closed | -$9.3M |
|
|
PETX
128
DELISTED
Aratana Therapeutics, Inc.
PETX
| – | – |
-43,445
| Closed | -$242K |
|
|
RLYP
129
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-252,000
| Closed | -$7.14M |
|
|
DYAX
130
DELISTED
DYAX CORPORATION
DYAX
| – | – |
-124,000
| Closed | -$4.67M |
|